Symbols / BDMD
BDMD Chart
About
Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; long microwave ablation needles; and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, as well as soft tissue ablation. It sells its products through third-party distributors. Baird Medical Investment Holdings Limited was founded in 2012 and is based in Guangzhou, China.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 67.21M |
| Enterprise Value | 65.23M | Income | -3.17M | Sales | 31.86M |
| Book/sh | 1.34 | Cash/sh | 0.09 | Dividend Yield | — |
| Payout | 0.00% | Employees | 143 | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | 2.11 | P/B | 1.37 | P/C | — |
| EV/EBITDA | 70.95 | EV/Sales | 2.05 | Quick Ratio | 1.22 |
| Current Ratio | 1.71 | Debt/Eq | 63.33 | LT Debt/Eq | — |
| EPS (ttm) | -0.11 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | -39.40% | Earnings | — | ROA | -0.20% |
| ROE | -8.03% | ROIC | — | Gross Margin | 86.94% |
| Oper. Margin | -131.30% | Profit Margin | -9.95% | Shs Outstand | 36.73M |
| Shs Float | 7.72M | Short Float | 0.28% | Short Ratio | 0.29 |
| Short Interest | — | 52W High | 7.26 | 52W Low | 0.76 |
| Beta | -1.08 | Avg Volume | 1.35M | Volume | 2.34M |
| Target Price | — | Recom | None | Prev Close | $1.70 |
| Price | $1.83 | Change | 7.65% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
- Needle-based thyroid therapy avoiding surgery scars heads to 3 US conferences - Stock Titan hu, 19 Feb 2026 13
- Baird Medical Investment Holdings Limited (NASDAQ:BDMD) Stock's 28% Dive Might Signal An Opportunity But It Requires Some Scrutiny - simplywall.st ue, 07 Oct 2025 07
- BDMD Stock Analysis: Key Insights and Market Trends - timothysykes.com Fri, 20 Feb 2026 21
- Declining Stock and Solid Fundamentals: Is The Market Wrong About Baird Medical Investment Holdings Limited (NASDAQ:BDMD)? - Yahoo Finance Wed, 01 Oct 2025 07
- 12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga ue, 17 Feb 2026 17
- Baird Medical names Mark Saxton as US subsidiary CEO - Investing.com Wed, 03 Dec 2025 08
- Inside Baird Medical’s US–Japan push for non-surgical thyroid care - Stock Titan Mon, 09 Feb 2026 08
- BDMD Soars Amid Positive Earnings and Market Expansion - timothysykes.com Fri, 20 Feb 2026 21
- Could The Market Be Wrong About Baird Medical Investment Holdings Limited (NASDAQ:BDMD) Given Its Attractive Financial Prospects? - simplywall.st Sat, 27 Sep 2025 07
- New Zealand partner to help Baird Medical speed global device rollout - Stock Titan Mon, 26 Jan 2026 08
- Baird Medical Investment Holdings Ltd (BDMD) Live Share Price, Invest From India - INDmoney Fri, 18 Apr 2025 12
- BDMD - Finviz Wed, 02 Oct 2024 14
- Baird Medical Lists in the U.S. on the Nasdaq Exchange - PR Newswire Wed, 09 Oct 2024 07
- With 51% ownership, Baird Medical Investment Holdings Limited (NASDAQ:BDMD) insiders have a lot at stake - Yahoo Finance Wed, 12 Feb 2025 08
- Minimally invasive treatment tech gains approval in Pakistan, Vietnam - Stock Titan Wed, 07 Jan 2026 08
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.11 | 0.14 | 0.12 | 0.19 |
| NormalizedEBITDA | 16.17M | 14.03M | 16.29M | 14.16M |
| NetIncomeFromContinuingOperationNetMinorityInterest | 12.45M | 10.55M | 12.57M | 10.09M |
| ReconciledDepreciation | 1.51M | 1.38M | 1.47M | 1.40M |
| ReconciledCostOfRevenue | 4.38M | 4.23M | 7.05M | 4.54M |
| EBITDA | 16.17M | 14.03M | 16.29M | 14.16M |
| EBIT | 14.66M | 12.65M | 14.82M | 12.76M |
| NetInterestIncome | -576.36K | -284.27K | -290.72K | -151.59K |
| InterestExpense | 576.75K | 285.83K | 299.27K | 153.92K |
| InterestIncome | 393.00 | 1.56K | 8.55K | 2.33K |
| NormalizedIncome | 12.45M | 10.55M | 12.57M | 10.09M |
| NetIncomeFromContinuingAndDiscontinuedOperation | 12.45M | 10.55M | 12.57M | 10.09M |
| TotalExpenses | 21.72M | 18.80M | 20.08M | 14.63M |
| TotalOperatingIncomeAsReported | 15.32M | 11.86M | 13.63M | 11.92M |
| DilutedAverageShares | 25.63M | 25.56M | 25.56M | 25.56M |
| BasicAverageShares | 25.56M | 25.56M | 25.56M | 25.56M |
| DilutedEPS | 0.49 | 0.41 | 0.49 | 0.39 |
| BasicEPS | 0.49 | 0.41 | 0.49 | 0.39 |
| DilutedNIAvailtoComStockholders | 12.50M | 10.55M | 12.57M | 10.09M |
| AverageDilutionEarnings | 50.75K | 0.00 | 0.00 | |
| NetIncomeCommonStockholders | 12.45M | 10.55M | 12.57M | 10.09M |
| NetIncome | 12.45M | 10.55M | 12.57M | 10.09M |
| MinorityInterests | -144.73K | -112.20K | -206.22K | -93.97K |
| NetIncomeIncludingNoncontrollingInterests | 12.60M | 10.66M | 12.77M | 10.18M |
| NetIncomeContinuousOperations | 12.60M | 10.66M | 12.77M | 10.18M |
| TaxProvision | 1.49M | 1.70M | 1.75M | 2.42M |
| PretaxIncome | 14.09M | 12.36M | 14.52M | 12.61M |
| OtherIncomeExpense | -651.66K | -10.21K | -194.58K | -335.07K |
| OtherNonOperatingIncomeExpenses | -651.66K | -10.21K | -194.58K | -335.07K |
| NetNonOperatingInterestIncomeExpense | -576.36K | -284.27K | -290.72K | -151.59K |
| InterestExpenseNonOperating | 576.75K | 285.83K | 299.27K | 153.92K |
| InterestIncomeNonOperating | 393.00 | 1.56K | 8.55K | 2.33K |
| OperatingIncome | 15.32M | 12.65M | 15.01M | 13.09M |
| OperatingExpense | 17.34M | 14.58M | 13.03M | 10.09M |
| OtherOperatingExpenses | -266.00 | -791.96K | -1.38M | -1.18M |
| ProvisionForDoubtfulAccounts | 1.20M | 2.20M | 400.00K | |
| ResearchAndDevelopment | 6.17M | 4.27M | 3.86M | 1.04M |
| SellingGeneralAndAdministration | 9.96M | 8.89M | 10.15M | 10.22M |
| SellingAndMarketingExpense | 4.06M | 2.55M | 3.59M | 3.57M |
| GeneralAndAdministrativeExpense | 5.90M | 6.35M | 6.56M | 6.65M |
| OtherGandA | 5.90M | 6.35M | 6.56M | 6.65M |
| GrossProfit | 32.65M | 27.23M | 28.04M | 23.18M |
| CostOfRevenue | 4.38M | 4.23M | 7.05M | 4.54M |
| TotalRevenue | 37.04M | 31.46M | 35.09M | 27.72M |
| OperatingRevenue | 37.04M | 31.46M | 35.09M | 27.72M |
| Line Item | 2024-12-31 | |||
|---|---|---|---|---|
| TreasurySharesNumber | 10.17M | |||
| OrdinarySharesNumber | 25.56M | 25.56M | 35.45M | 35.45M |
| ShareIssued | 35.73M | 25.56M | 35.45M | 35.45M |
| NetDebt | 17.51M | 9.09M | 4.52M | |
| TotalDebt | 20.88M | 11.51M | 7.44M | 2.93M |
| TangibleBookValue | 39.58M | 35.67M | 25.82M | 15.25M |
| InvestedCapital | 60.14M | 46.35M | 32.17M | 17.42M |
| WorkingCapital | 26.79M | 21.11M | 17.74M | 11.69M |
| NetTangibleAssets | 39.58M | 35.67M | 25.82M | 15.25M |
| CapitalLeaseObligations | 401.00K | 916.01K | 1.21M | 894.57K |
| CommonStockEquity | 39.66M | 35.75M | 25.93M | 15.38M |
| PreferredStockEquity | 29.00 | |||
| TotalCapitalization | 43.10M | 37.36M | 25.93M | 15.38M |
| TotalEquityGrossMinorityInterest | 39.76M | 35.71M | 25.78M | 15.02M |
| MinorityInterest | 101.34K | -43.39K | -155.59K | -353.41K |
| StockholdersEquity | 39.66M | 35.75M | 25.93M | 15.38M |
| GainsLossesNotAffectingRetainedEarnings | 1.45M | 2.50M | 3.12M | 3.31M |
| OtherEquityAdjustments | 1.45M | 2.50M | 3.12M | 3.31M |
| RetainedEarnings | 26.76M | 14.39M | 3.96M | -6.78M |
| AdditionalPaidInCapital | 11.44M | 18.85M | 18.85M | 18.85M |
| CapitalStock | 2.58K | 2.56K | 2.94K | 1.00 |
| CommonStock | 2.56K | 2.56K | 2.94K | 1.00 |
| PreferredStock | 29.00 | 0.00 | ||
| TotalLiabilitiesNetMinorityInterest | 38.20M | 21.00M | 16.84M | 10.26M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 3.58M | 2.03M | 816.88K | 494.12K |
| LongTermDebtAndCapitalLeaseObligation | 3.58M | 2.03M | 816.88K | 494.12K |
| LongTermCapitalLeaseObligation | 136.68K | 412.12K | 816.88K | 494.12K |
| LongTermDebt | 3.44M | 1.61M | ||
| CurrentLiabilities | 34.62M | 18.98M | 16.02M | 9.77M |
| CurrentDeferredLiabilities | 837.34K | 593.29K | 712.83K | 731.43K |
| CurrentDeferredRevenue | 792.10K | 499.90K | 692.51K | 701.53K |
| CurrentDeferredTaxesLiabilities | 45.24K | 93.39K | 20.32K | 29.91K |
| CurrentDebtAndCapitalLeaseObligation | 17.30M | 9.49M | 6.62M | 2.44M |
| CurrentCapitalLeaseObligation | 264.32K | 503.89K | 389.63K | 400.44K |
| CurrentDebt | 17.03M | 8.98M | 6.23M | 2.04M |
| OtherCurrentBorrowings | 867.77K | 817.49K | ||
| LineOfCredit | 16.17M | 8.17M | 6.23M | 2.04M |
| PayablesAndAccruedExpenses | 16.49M | 8.89M | 8.69M | 6.59M |
| CurrentAccruedExpenses | 2.52M | 864.69K | 104.95K | 158.04K |
| Payables | 13.97M | 8.03M | 8.58M | 6.44M |
| OtherPayable | 6.14M | 2.92M | 2.55M | 1.30M |
| DuetoRelatedPartiesCurrent | 3.70M | 3.79M | 4.02M | 4.06M |
| TotalTaxPayable | 2.87M | 770.95K | 1.80M | 739.40K |
| IncomeTaxPayable | 79.17K | 448.23K | 714.47K | 297.68K |
| AccountsPayable | 1.25M | 550.19K | 215.86K | 340.21K |
| TotalAssets | 77.96M | 56.71M | 42.62M | 25.28M |
| TotalNonCurrentAssets | 16.55M | 16.63M | 8.85M | 3.83M |
| OtherNonCurrentAssets | 121.51K | 152.45K | 45.95K | 80.14K |
| NonCurrentPrepaidAssets | 8.02M | 7.70M | 5.76M | 218.09K |
| NonCurrentDeferredAssets | 714.46K | 1.69M | 206.22K | 79.78K |
| NonCurrentDeferredTaxesAssets | 714.46K | 814.37K | 206.22K | 79.78K |
| GoodwillAndOtherIntangibleAssets | 74.30K | 84.85K | 110.62K | 128.94K |
| OtherIntangibleAssets | 16.53K | 25.48K | 49.48K | 62.77K |
| Goodwill | 57.77K | 59.38K | 61.14K | 66.17K |
| NetPPE | 7.62M | 7.00M | 2.73M | 3.33M |
| AccumulatedDepreciation | -4.59M | -3.58M | -2.66M | -2.01M |
| GrossPPE | 12.21M | 10.58M | 5.39M | 5.33M |
| Leases | 4.33M | 4.66M | 2.61M | 2.82M |
| OtherProperties | 807.08K | 1.20M | 1.62M | 1.32M |
| MachineryFurnitureEquipment | 7.08M | 4.72M | 1.16M | 1.19M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 61.42M | 40.08M | 33.76M | 21.45M |
| OtherCurrentAssets | 295.75K | 120.48K | 197.00K | 304.29K |
| PrepaidAssets | 10.27M | 5.81M | 5.80M | 3.25M |
| Inventory | 1.30M | 1.14M | 1.29M | 3.06M |
| FinishedGoods | 717.31K | 312.87K | 477.35K | 2.15M |
| WorkInProcess | 230.35K | 313.35K | 330.75K | 399.76K |
| RawMaterials | 348.91K | 516.35K | 485.15K | 507.56K |
| Receivables | 46.58M | 31.49M | 24.76M | 11.81M |
| DuefromRelatedPartiesCurrent | 2.86K | 394.58K | 391.72K | 79.26K |
| TaxesReceivable | 0.00 | 556.80K | ||
| AccountsReceivable | 46.58M | 31.10M | 24.37M | 11.17M |
| AllowanceForDoubtfulAccountsReceivable | -3.99M | -2.84M | -644.67K | -234.19K |
| GrossAccountsReceivable | 50.57M | 33.94M | 25.02M | 11.41M |
| CashCashEquivalentsAndShortTermInvestments | 2.97M | 1.51M | 1.71M | 3.03M |
| CashAndCashEquivalents | 2.97M | 1.51M | 1.71M | 3.03M |
| CashFinancial | 2.97M | 1.51M | 1.71M | 3.03M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -9.17M | -3.66M | -5.47M | 3.87M |
| RepaymentOfDebt | -11.79M | -7.68M | -4.61M | -3.65M |
| IssuanceOfDebt | 22.10M | 12.15M | 9.07M | 3.57M |
| IssuanceOfCapitalStock | 2.90M | 0.00 | 0.00 | |
| CapitalExpenditure | -2.85M | -2.64M | -5.95M | -1.39M |
| InterestPaidSupplementalData | 497.25K | 261.32K | 243.84K | 90.08K |
| IncomeTaxPaidSupplementalData | 1.84M | 2.64M | 1.44M | 3.91M |
| EndCashPosition | 2.97M | 1.51M | 1.71M | 3.03M |
| BeginningCashPosition | 1.51M | 1.71M | 3.03M | 1.07M |
| EffectOfExchangeRateChanges | -94.27K | -3.11K | -297.65K | 18.55K |
| ChangesInCash | 1.55M | -197.33K | -1.02M | 1.94M |
| FinancingCashFlow | 10.72M | 3.46M | 4.41M | -1.93M |
| CashFlowFromContinuingFinancingActivities | 10.72M | 3.46M | 4.41M | -1.93M |
| NetOtherFinancingCharges | -2.49M | -1.01M | -46.40K | 3.59M |
| CashDividendsPaid | 0.00 | -5.43M | ||
| CommonStockDividendPaid | 0.00 | -5.43M | ||
| NetCommonStockIssuance | 2.90M | 0.00 | 0.00 | |
| CommonStockIssuance | 2.90M | 0.00 | 0.00 | |
| NetIssuancePaymentsOfDebt | 10.31M | 4.47M | 4.46M | -88.58K |
| NetShortTermDebtIssuance | 8.34M | 2.12M | 4.46M | 620.08K |
| ShortTermDebtPayments | -10.98M | -7.48M | -4.61M | -2.95M |
| ShortTermDebtIssuance | 19.32M | 9.60M | 9.07M | 3.57M |
| NetLongTermDebtIssuance | 1.97M | 2.35M | 0.00 | -708.66K |
| LongTermDebtPayments | -806.76K | -194.04K | 0.00 | -708.66K |
| LongTermDebtIssuance | 2.78M | 2.55M | 0.00 | |
| InvestingCashFlow | -2.85M | -2.64M | -5.92M | -1.39M |
| CashFlowFromContinuingInvestingActivities | -2.85M | -2.64M | -5.92M | -1.39M |
| NetIntangiblesPurchaseAndSale | 0.00 | 0.00 | -44.82K | 0.00 |
| PurchaseOfIntangibles | 0.00 | 0.00 | -44.82K | 0.00 |
| NetPPEPurchaseAndSale | -2.85M | -2.64M | -5.88M | -1.39M |
| SaleOfPPE | 0.00 | 0.00 | 32.66K | 561.00 |
| PurchaseOfPPE | -2.85M | -2.64M | -5.91M | -1.39M |
| OperatingCashFlow | -6.31M | -1.02M | 485.97K | 5.26M |
| CashFlowFromContinuingOperatingActivities | -6.31M | -1.02M | 485.97K | 5.26M |
| ChangeInWorkingCapital | -21.70M | -14.86M | -14.05M | -6.57M |
| ChangeInOtherWorkingCapital | 310.15K | -173.10K | 45.45K | -95.91K |
| ChangeInOtherCurrentLiabilities | -497.45K | -253.60K | 389.48K | -736.31K |
| ChangeInOtherCurrentAssets | 0.00 | -9.10K | -881.43K | -145.89K |
| ChangeInPayablesAndAccruedExpense | 1.31M | 582.95K | 2.38M | 624.37K |
| ChangeInAccruedExpense | -1.57M | 1.21M | 1.34M | 464.12K |
| ChangeInPayable | 2.88M | -630.94K | 1.04M | 160.25K |
| ChangeInAccountPayable | 727.80K | 341.52K | -100.93K | 274.31K |
| ChangeInTaxPayable | 2.15M | -972.47K | 1.14M | -114.06K |
| ChangeInIncomeTaxPayable | 2.15M | -972.47K | 1.14M | -114.06K |
| ChangeInPrepaidAssets | -4.84M | -5.44M | -3.45M | -525.78K |
| ChangeInInventory | -187.54K | 113.66K | 1.57M | -2.20M |
| ChangeInReceivables | -17.80M | -9.67M | -14.10M | -3.49M |
| ChangesInAccountReceivables | -17.80M | -9.67M | -14.84M | -2.94M |
| ProvisionandWriteOffofAssets | 1.25M | 2.34M | 439.00K | 231.35K |
| DeferredTax | 32.77K | -541.99K | -143.32K | -45.38K |
| DeferredIncomeTax | 32.77K | -541.99K | -143.32K | -45.38K |
| DepreciationAmortizationDepletion | 1.51M | 1.38M | 1.47M | 1.40M |
| DepreciationAndAmortization | 1.51M | 1.38M | 1.47M | 1.40M |
| Depreciation | 1.51M | 1.38M | 1.47M | 1.40M |
| OperatingGainsLosses | -5.42K | 54.70K | ||
| GainLossOnSaleOfPPE | 0.00 | 0.00 | -5.42K | 54.70K |
| NetIncomeFromContinuingOperations | 12.60M | 10.66M | 12.77M | 10.18M |
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for BDMD
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|